Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations.

One of the 20 or so human amyloid diseases is associated with the deposition in vital organs of full-length mutational variants of the antibacterial protein lysozyme. Here, we report experimental data that permit a detailed comparison to be made of the behaviour of two of these amyloidogenic variant...

Descripción completa

Detalles Bibliográficos
Autores principales: Dumoulin, M, Canet, D, Last, A, Pardon, E, Archer, D, Muyldermans, S, Wyns, L, Matagne, A, Robinson, C, Redfield, C, Dobson, C
Formato: Journal article
Lenguaje:English
Publicado: 2005
_version_ 1826279568059662336
author Dumoulin, M
Canet, D
Last, A
Pardon, E
Archer, D
Muyldermans, S
Wyns, L
Matagne, A
Robinson, C
Redfield, C
Dobson, C
author_facet Dumoulin, M
Canet, D
Last, A
Pardon, E
Archer, D
Muyldermans, S
Wyns, L
Matagne, A
Robinson, C
Redfield, C
Dobson, C
author_sort Dumoulin, M
collection OXFORD
description One of the 20 or so human amyloid diseases is associated with the deposition in vital organs of full-length mutational variants of the antibacterial protein lysozyme. Here, we report experimental data that permit a detailed comparison to be made of the behaviour of two of these amyloidogenic variants, I56T and D67H, under identical conditions. Hydrogen/deuterium exchange experiments monitored by NMR and mass spectrometry reveal that, despite their different locations and the different effects of the two mutations on the structure of the native state of lysozyme, both mutations cause a cooperative destabilisation of a remarkably similar segment of the structure, comprising in both cases the beta-domain and the adjacent C-helix. As a result, both variant proteins populate transiently a closely similar, partially unstructured intermediate in which the beta-domain and the adjacent C-helix are substantially and simultaneously unfolded, whereas the three remaining alpha-helices that form the core of the alpha-domain still have their native-like structure. We show, in addition, that the binding of a camel antibody fragment, cAb-HuL6, which was raised against wild-type lysozyme, restores to both variant proteins the stability and cooperativity characteristic of the wild-type protein; as a consequence, it inhibits the formation of amyloid fibrils by both variants. These results indicate that the reduction in global cooperativity, and the associated ability to populate transiently a specific, partly unfolded intermediate state under physiologically relevant conditions, is a common feature underlying the behaviour of these two pathogenic mutations. The formation of intermolecular interactions between lysozyme molecules that are in this partially unfolded state is therefore likely to be the fundamental trigger of the aggregation process that ultimately leads to the formation and deposition in tissue of amyloid fibrils.
first_indexed 2024-03-07T00:00:41Z
format Journal article
id oxford-uuid:75d5503e-4ad4-48fc-9547-1c7f08a404b0
institution University of Oxford
language English
last_indexed 2024-03-07T00:00:41Z
publishDate 2005
record_format dspace
spelling oxford-uuid:75d5503e-4ad4-48fc-9547-1c7f08a404b02022-03-26T20:11:55ZReduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:75d5503e-4ad4-48fc-9547-1c7f08a404b0EnglishSymplectic Elements at Oxford2005Dumoulin, MCanet, DLast, APardon, EArcher, DMuyldermans, SWyns, LMatagne, ARobinson, CRedfield, CDobson, COne of the 20 or so human amyloid diseases is associated with the deposition in vital organs of full-length mutational variants of the antibacterial protein lysozyme. Here, we report experimental data that permit a detailed comparison to be made of the behaviour of two of these amyloidogenic variants, I56T and D67H, under identical conditions. Hydrogen/deuterium exchange experiments monitored by NMR and mass spectrometry reveal that, despite their different locations and the different effects of the two mutations on the structure of the native state of lysozyme, both mutations cause a cooperative destabilisation of a remarkably similar segment of the structure, comprising in both cases the beta-domain and the adjacent C-helix. As a result, both variant proteins populate transiently a closely similar, partially unstructured intermediate in which the beta-domain and the adjacent C-helix are substantially and simultaneously unfolded, whereas the three remaining alpha-helices that form the core of the alpha-domain still have their native-like structure. We show, in addition, that the binding of a camel antibody fragment, cAb-HuL6, which was raised against wild-type lysozyme, restores to both variant proteins the stability and cooperativity characteristic of the wild-type protein; as a consequence, it inhibits the formation of amyloid fibrils by both variants. These results indicate that the reduction in global cooperativity, and the associated ability to populate transiently a specific, partly unfolded intermediate state under physiologically relevant conditions, is a common feature underlying the behaviour of these two pathogenic mutations. The formation of intermolecular interactions between lysozyme molecules that are in this partially unfolded state is therefore likely to be the fundamental trigger of the aggregation process that ultimately leads to the formation and deposition in tissue of amyloid fibrils.
spellingShingle Dumoulin, M
Canet, D
Last, A
Pardon, E
Archer, D
Muyldermans, S
Wyns, L
Matagne, A
Robinson, C
Redfield, C
Dobson, C
Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations.
title Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations.
title_full Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations.
title_fullStr Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations.
title_full_unstemmed Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations.
title_short Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations.
title_sort reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations
work_keys_str_mv AT dumoulinm reducedglobalcooperativityisacommonfeatureunderlyingtheamyloidogenicityofpathogeniclysozymemutations
AT canetd reducedglobalcooperativityisacommonfeatureunderlyingtheamyloidogenicityofpathogeniclysozymemutations
AT lasta reducedglobalcooperativityisacommonfeatureunderlyingtheamyloidogenicityofpathogeniclysozymemutations
AT pardone reducedglobalcooperativityisacommonfeatureunderlyingtheamyloidogenicityofpathogeniclysozymemutations
AT archerd reducedglobalcooperativityisacommonfeatureunderlyingtheamyloidogenicityofpathogeniclysozymemutations
AT muyldermanss reducedglobalcooperativityisacommonfeatureunderlyingtheamyloidogenicityofpathogeniclysozymemutations
AT wynsl reducedglobalcooperativityisacommonfeatureunderlyingtheamyloidogenicityofpathogeniclysozymemutations
AT matagnea reducedglobalcooperativityisacommonfeatureunderlyingtheamyloidogenicityofpathogeniclysozymemutations
AT robinsonc reducedglobalcooperativityisacommonfeatureunderlyingtheamyloidogenicityofpathogeniclysozymemutations
AT redfieldc reducedglobalcooperativityisacommonfeatureunderlyingtheamyloidogenicityofpathogeniclysozymemutations
AT dobsonc reducedglobalcooperativityisacommonfeatureunderlyingtheamyloidogenicityofpathogeniclysozymemutations